News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
31,269 Results
Type
Article (1755)
Press Release (29514)
Section
Business (9208)
Career Advice (8)
Deals (2350)
Drug Development (3084)
Employer Resources (2)
FDA (819)
Job Trends (576)
News (16056)
Policy (1517)
Tag
Academia (19)
Allergies (1)
Alliances (2329)
Alzheimer's disease (16)
Approvals (830)
Artificial intelligence (4)
Autoimmune disease (1)
Bankruptcy (14)
Best Places to Work (308)
Brain cancer (1)
Breast cancer (5)
Cancer (51)
Cardiovascular disease (4)
Career advice (7)
Career pathing (1)
CAR-T (7)
Cell therapy (20)
Clinical research (2736)
Collaboration (24)
Compensation (17)
COVID-19 (31)
C-suite (19)
Cystic fibrosis (1)
Data (87)
Depression (3)
Diabetes (15)
Diagnostics (143)
Digital health (2)
Diversity, equity & inclusion (1)
Earnings (3628)
Employer resources (2)
Events (3327)
Executive appointments (44)
FDA (865)
Funding (19)
Gene therapy (4)
GLP-1 (14)
Government (52)
Guidances (8)
Healthcare (436)
Indications (1)
Infectious disease (36)
Inflammatory bowel disease (1)
Intellectual property (2)
IPO (729)
Job creations (282)
Job search strategy (6)
Layoffs (6)
Legal (534)
Liver cancer (2)
Lung cancer (5)
Management (1)
Manufacturing (7)
MASH (1)
Medical device (391)
Medtech (391)
Mergers & acquisitions (1642)
Metabolic disorders (22)
Neuropsychiatric disorders (2)
Neuroscience (31)
NextGen: Class of 2025 (87)
Non-profit (21)
Now hiring (1)
Obesity (6)
Opinion (2)
Ovarian cancer (3)
Parkinson's disease (4)
Partnered (1)
Patents (5)
Patient recruitment (7)
Peanut (1)
People (3171)
Phase I (634)
Phase II (997)
Phase III (1139)
Pipeline (57)
Postmarket research (249)
Preclinical (191)
Press Release (1)
Prostate cancer (2)
Radiopharmaceuticals (12)
Rare diseases (1)
Real estate (174)
Regulatory (983)
Reports (7)
Research institute (34)
RSV (4)
Schizophrenia (3)
Series A (4)
Series B (3)
Spinal muscular atrophy (1)
Startups (132)
Vaccines (10)
Date
Today (4)
Last 7 days (15)
Last 30 days (69)
Last 365 days (945)
2025 (428)
2024 (1130)
2023 (1424)
2022 (3610)
2021 (3274)
2020 (2698)
2019 (1639)
2018 (1217)
2017 (1691)
2016 (1630)
2015 (2324)
2014 (1558)
2013 (1070)
2012 (1016)
2011 (962)
2010 (936)
Location
Africa (16)
Alabama (1)
Arizona (1)
Arkansas (1)
Asia (913)
Australia (127)
California (90)
Canada (26)
China (3)
Colorado (2)
Connecticut (2)
Delaware (4)
Europe (16837)
Florida (9)
Georgia (1)
Illinois (10)
India (3)
Indiana (4)
Iowa (1)
Japan (4)
Kansas (1)
Maryland (30)
Massachusetts (155)
Minnesota (1)
Missouri (1)
Nebraska (1)
Nevada (1)
New Hampshire (1)
New Jersey (37)
New York (31)
North Carolina (54)
Northern California (36)
Ohio (3)
Oregon (1)
Pennsylvania (69)
South America (27)
Southern California (46)
Texas (4)
United States (522)
Utah (2)
Virginia (18)
Washington State (13)
31,269 Results for "abcam plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Abcam plc: All Resolutions Withdrawn at Abcam’s EGM
Abcam plc, a global leader in the supply of life science research tools, held an Extraordinary General Meeting of its shareholders that was convened following a requisition notice from Dr. Jonathan Milner dated May 30, 2023.
July 12, 2023
·
2 min read
Business
Abcam plc: FY2024 Guidance
Abcam plc, a global leader in the supply of life science research tools, provides the following updates.
June 26, 2023
·
9 min read
Deals
Danaher Completes Acquisition of Abcam
Danaher Corporation (NYSE:DHR) (“Danaher”) announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) (“Abcam”).
December 6, 2023
·
1 min read
Genetown
ABCAM PLC: Trading Update
Abcam plc, a global leader in the supply of life science research tools, provides the following preliminary trading update for the quarter ending 31 March 2023.
April 13, 2023
·
9 min read
Genetown
Abcam plc Interim Results for the Six-Month Period Ended 30 June 2023
Abcam plc, a global leader in the supply of life science research tools, announces its interim results for the six-month period ended 30 June 2023.
August 31, 2023
·
40 min read
Genetown
ABCAM PLC Comments on Investor Engagement
Abcam plc, a global leader in the supply of life science research tools, notes the Form 13D filed by founder and former director Dr Jonathan Milner and related press reports.
May 1, 2023
·
8 min read
Genetown
ABCAM PLC: Statement on calling an Extraordinary General Meeting
Abcam plc, a global leader in the supply of life science research tools, notes that it has received a notice from Dr. Jonathan Milner seeking to require the Board of Directors to convene an Extraordinary General Meeting.
May 30, 2023
·
4 min read
Genetown
ABCAM PLC Result of Annual General Meeting - May 17, 2023
Abcam plc, a global leader in the supply of life science research tools, announces the voting results from the Annual General Meeting.
May 17, 2023
·
4 min read
Genetown
Abcam, plc Publication of 2022 Annual Report and Accounts and Notice of Annual General Meeting
Abcam plc announces that, following release on 20 March 2023 of its final results for the year ended 31 December 2022 on Form 20-F with the Securities and Exchange Commission, the Abcam plc Annual Report and Accounts 2022 have been published and are available on the Abcam plc website
March 30, 2023
·
2 min read
Business
Abcam appoints Markus Lusser as new President
Abcam today announced the appointment of Markus Lusser as President.
March 18, 2024
·
2 min read
1 of 3,127
Next
